Angelini pharma
  • Angelini Pharma Worldwide
    • Italy
    • Poland
    • Spain
  • Angelini Pharma
  • Who we are

    • Who We Are
    • Vision, mission & values
    • Key facts and events
    • People
  • Core areas

    • Mental Health
    • Central Nervous System
    • Rare Diseases
    • Consumer Health
  • From pipeline to health aids

    • Pipeline
    • Sites
  • Our Partnerships

    • Research & Academic Centers and Scientific Institutions
    • Partnering
  • Our Responsibility

    • Sustainability
    • Ethics
    • Quality policy
    • Transparency
  • Media

    • News
    • Press releases
    • Press kit
    • Magazine
    • Media center
  • Career Opportunities
  • Open main menu
  • Open main menu
  • Search

    Search

  1. Angelini Pharma
  2. Core areas
  3. The Lancet

The Lancet

The Lancet
  • All articles
  • Mental Health
  • Pain
  • Rare Diseases
  • Consumer Health
  1. Associations between age and the course of major depressive disorder: a 2-year longitudinal cohort study

    Large-scale studies with a broad age range are needed to properly address this issue.

    Associations between age and the course of major depressive disorder: a 2-year longitudinal cohort study
  2. Breakthrough Cancer Pain Influences General Activities and Pain Management: A Comparison of Patients with and without Breakthrough Cancer Pain.

    BTcP has a negative impact on general activities and pain management in oncological patients.

    Breakthrough Cancer Pain Influences General Activities and Pain Management: A Comparison of Patients with and without Breakthrough Cancer Pain.
  3. Efficacy and cost-effectiveness of therapist-guided internet cognitive behavioural therapy for paediatric anxiety disorders: a single-centre, single-blind, randomised controlled trial.

    Efficacy and cost-effectiveness of therapist-guided internet cognitive behavioural therapy for paediatric anxiety disorders: a single-centre, single-blind, randomised controlled trial.
load more

See also

  1. Mental Health

    Mental Health
  2. Central Nervous System

    Central Nervous System
  3. Rare Diseases

    Rare Diseases
  4. Consumer Health

    Consumer Health
Angelini pharma
  • Terms of use
  • Privacy
  • Transparency
  • Cookie Policy
  • Contact
  • Site map
  • Credits
  • Twitter
  • Linkedin
  • Facebook
  • Instagram
  • YouTube
  • Top Employee

Angelini S.p.a. - Viale Amelia 70, 00181 Roma - P.IVA 01258691003 e C.F. Numero di iscrizione registro imprese: 03907010585 - Ufficio del registro delle imprese: Roma - Capitale: € 165.000.000 I.V.
Copyright 2021 © Angelini S.p.a. - All Rights Reserved

Close menu